Stephen A. Barat

Dr. Barat has served as the Senior Vice President of Therapeutics since October 2021. Prior to joining us, Dr. Barat was the U.S. Head, Non-clinical Safety Leaders in Non-clinical Safety Assessment at Janssen, where he led a large team that supported programs in all phases of discovery and development, from target assessment and lead optimization through candidate selection, early/late-stage development and registration. Before Janssen, he served as Vice President, Preclinical Research and Early Development at Scynexis and held additional senior roles at Allergan (Actavis/Forest Laboratories) and Schering-Plough/Merck. During his career, Dr. Barat has contributed to the development and registration of 15 new drug products, earned international recognition as a speaker and continuing education faculty on drug development topics, and has been an active member of industry working groups with USP and PQRI. A graduate of Rutgers University, Dr. Barat earned his Ph.D. in biomedical sciences, pharmacology and toxicology from the University of Medicine and Dentistry - New Jersey Medical School.